WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006122431) TRIAZINE COMPOUNDS AND COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/122431    International Application No.:    PCT/CA2006/000832
Publication Date: 23.11.2006 International Filing Date: 19.05.2006
IPC:
A61K 31/53 (2006.01), A61K 38/20 (2006.01), A61K 45/08 (2006.01), A61K 47/10 (2006.01), A61K 47/16 (2006.01), A61P 35/00 (2006.01)
Applicants: PROMETIC BIOSCIENCES INC. [CA/CA]; 8168 Montview Road, Montreal, Quebec H4P 2L7 (CA) (For All Designated States Except US).
GAGNON, Lyne [CA/CA]; (CA) (For US Only).
ZACHARIE, Boulos [CA/CA]; (CA) (For US Only).
PENNEY, Christopher [CA/CA]; (CA) (For US Only)
Inventors: GAGNON, Lyne; (CA).
ZACHARIE, Boulos; (CA).
PENNEY, Christopher; (CA)
Agent: DUBUC, J.; Goudreau Gage Dubuc, 2000 McGill College Avenue, Suite 2200, Montréal, Québec H3A 3H3 (CA)
Priority Data:
60/682,374 19.05.2005 US
Title (EN) TRIAZINE COMPOUNDS AND COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCERS
(FR) COMPOSES DE TRIAZINE ET LEURS COMPOSITIONS UTILISES DANS LE TRAITEMENT DES CANCERS
Abstract: front page image
(EN)Compounds useful in the treatment of metastatic melanoma and other cancers containing a triazine ring scaffold are described. These compounds may be classified into two groups: (1) two disubstituted triazine rings are covalently linked by an organic linker to each other and (2) one trisubstituted triazine ring.
(FR)L'invention porte sur des composés utiles dans le traitement des mélanomes métastatiques et d'autres cancers, ces composés présentant une structure de noyau triazine. Ces composés peuvent être classés en deux groupes: (1) deux noyaux triazine disubstitués sont liés l'un à l'autre de manière covalente par un lieur organique et (2) un noyau triazine trisubstitué.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)